首页 › 基金 › General Catalyst Group Management, LLC › PBLS

General Catalyst Group Management, LLC 对 PBLS 的持仓历史

PARABILIS MEDICINES INC · 医疗保健

General Catalyst Group Management, LLC 在 Q2 2026 的 13F 申报中披露持有 PBLS(PARABILIS MEDICINES INC)1,600,937 股,市值约 US$43.8M,约占其申报组合的 23.24%,在其申报持仓中市值排名第 2 位。 General Catalyst Group Management, LLC 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)1.60M 股
申报持仓市值$43.82M
组合权重23.24%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

General Catalyst Group Management, LLC 对 PBLS 的持仓演变

General Catalyst Group Management, LLC 于 Q2 2026 首次披露 PBLS 持仓:1,600,937 股(约 US$43.8M)。

逐季持仓明细

季度股数金额变化
Q2 2026 1.60M $43.82M 新进

关于 PBLS 与 13F 数据

PBLS(PARABILIS MEDICINES INC)属于医疗保健行业。我们追踪的基金中还有 89 只申报持有 PBLS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$791.9M), ARCH Venture Management, LLC (US$175.5M), venBio Partners LLC (US$144.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PBLS 的基金

查看 PBLS 的全部基金持有人 →

常见问题

How long has General Catalyst Group Management, LLC held PBLS?

General Catalyst Group Management, LLC has disclosed PBLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is General Catalyst Group Management, LLC's current position in PBLS?

As of Q2 2026, General Catalyst Group Management, LLC holds 1.60M shares of PBLS (PARABILIS MEDICINES INC), valued at $43.82M, representing 23.24% of its reported portfolio and ranking #2.

Has General Catalyst Group Management, LLC been buying or selling PBLS?

In the latest 13F filing (Q2 2026), General Catalyst Group Management, LLC newly opened its position in PBLS.

Which other funds hold PBLS?

Other major institutional holders of PBLS include RA CAPITAL MANAGEMENT, L.P., ARCH Venture Management, LLC, venBio Partners LLC, among 89 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.